Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 36876 | 72 | 26.5 | 26% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 350 | 3 | COMPLEMENT//MANNOSE BINDING LECTIN//IMMUNOLOGY | 35656 |
| 363 | 2 | COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | 17354 |
| 36876 | 1 | C2 FUNCTIONAL ASSAY//C4 SYNTHESIS//CHOLINE PHOSPHOLIPID METABOLITES | 72 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | C2 FUNCTIONAL ASSAY | authKW | 424107 | 1% | 100% | 1 |
| 2 | C4 SYNTHESIS | authKW | 424107 | 1% | 100% | 1 |
| 3 | CHOLINE PHOSPHOLIPID METABOLITES | authKW | 424107 | 1% | 100% | 1 |
| 4 | GENERAL ACTEOSIDE OF REHMANNIAE LEAVES | authKW | 424107 | 1% | 100% | 1 |
| 5 | GRANULOFIBROUS TISSUE | authKW | 424107 | 1% | 100% | 1 |
| 6 | HEMOLYTIC COMPLEMENT TEST | authKW | 424107 | 1% | 100% | 1 |
| 7 | PIPERAZINE FERULATE | authKW | 424107 | 1% | 100% | 1 |
| 8 | RADIAL IMMUNOHEMOLYSIS | authKW | 424107 | 1% | 100% | 1 |
| 9 | SURGICAL THREADS | authKW | 424107 | 1% | 100% | 1 |
| 10 | VIS MEDICATRIX NATURAE | authKW | 424107 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Rheumatology | 259 | 11% | 0% | 8 |
| 2 | Immunology | 203 | 26% | 0% | 19 |
| 3 | Pharmacology & Pharmacy | 201 | 32% | 0% | 23 |
| 4 | Medicine, Research & Experimental | 87 | 14% | 0% | 10 |
| 5 | Medical Laboratory Technology | 40 | 4% | 0% | 3 |
| 6 | Integrative & Complementary Medicine | 34 | 3% | 0% | 2 |
| 7 | Materials Science, Biomaterials | 17 | 3% | 0% | 2 |
| 8 | Chemistry, Medicinal | 10 | 4% | 0% | 3 |
| 9 | Biochemical Research Methods | 7 | 4% | 0% | 3 |
| 10 | Dermatology | 6 | 3% | 0% | 2 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | MR ONCOL SECT MR | 141368 | 1% | 33% | 1 |
| 2 | EQUIPE CYTOKINES RELAT MATERNO FOETALE | 70683 | 1% | 17% | 1 |
| 3 | CHINESE HERBAL MED | 4763 | 1% | 1% | 1 |
| 4 | U131 | 4197 | 1% | 1% | 1 |
| 5 | CHINESE MED ACUPUNCTURE | 3260 | 1% | 1% | 1 |
| 6 | POSTBACCALAUREATE CHINESE MED | 2770 | 1% | 1% | 1 |
| 7 | IND HUMAN ECOL | 1604 | 1% | 0% | 1 |
| 8 | HOSP HLTH CARE ADM | 845 | 1% | 0% | 1 |
| 9 | MANAGEMENT OFF HLTH DATA | 616 | 1% | 0% | 1 |
| 10 | INTEGRATED MED | 429 | 1% | 0% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION | 95412 | 8% | 4% | 6 |
| 2 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 3346 | 6% | 0% | 4 |
| 3 | IMMUNOPHARMACOLOGY | 2868 | 4% | 0% | 3 |
| 4 | JOURNAL DE BIOPHYSIQUE & MEDECINE NUCLEAIRE | 2435 | 1% | 1% | 1 |
| 5 | CELLS AND MATERIALS | 2108 | 1% | 0% | 1 |
| 6 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1414 | 6% | 0% | 4 |
| 7 | AGENTS AND ACTIONS | 1186 | 4% | 0% | 3 |
| 8 | EXPERIMENTAL AND CLINICAL IMMUNOGENETICS | 930 | 1% | 0% | 1 |
| 9 | PHARMACOLOGICAL REVIEWS | 604 | 1% | 0% | 1 |
| 10 | SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 574 | 3% | 0% | 2 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | C2 FUNCTIONAL ASSAY | 424107 | 1% | 100% | 1 | Search C2+FUNCTIONAL+ASSAY | Search C2+FUNCTIONAL+ASSAY |
| 2 | C4 SYNTHESIS | 424107 | 1% | 100% | 1 | Search C4+SYNTHESIS | Search C4+SYNTHESIS |
| 3 | CHOLINE PHOSPHOLIPID METABOLITES | 424107 | 1% | 100% | 1 | Search CHOLINE+PHOSPHOLIPID+METABOLITES | Search CHOLINE+PHOSPHOLIPID+METABOLITES |
| 4 | GENERAL ACTEOSIDE OF REHMANNIAE LEAVES | 424107 | 1% | 100% | 1 | Search GENERAL+ACTEOSIDE+OF+REHMANNIAE+LEAVES | Search GENERAL+ACTEOSIDE+OF+REHMANNIAE+LEAVES |
| 5 | GRANULOFIBROUS TISSUE | 424107 | 1% | 100% | 1 | Search GRANULOFIBROUS+TISSUE | Search GRANULOFIBROUS+TISSUE |
| 6 | HEMOLYTIC COMPLEMENT TEST | 424107 | 1% | 100% | 1 | Search HEMOLYTIC+COMPLEMENT+TEST | Search HEMOLYTIC+COMPLEMENT+TEST |
| 7 | PIPERAZINE FERULATE | 424107 | 1% | 100% | 1 | Search PIPERAZINE+FERULATE | Search PIPERAZINE+FERULATE |
| 8 | RADIAL IMMUNOHEMOLYSIS | 424107 | 1% | 100% | 1 | Search RADIAL+IMMUNOHEMOLYSIS | Search RADIAL+IMMUNOHEMOLYSIS |
| 9 | SURGICAL THREADS | 424107 | 1% | 100% | 1 | Search SURGICAL+THREADS | Search SURGICAL+THREADS |
| 10 | VIS MEDICATRIX NATURAE | 424107 | 1% | 100% | 1 | Search VIS+MEDICATRIX+NATURAE | Search VIS+MEDICATRIX+NATURAE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | OBRIEN, WM , BAGBY, GF , (1987) CARPROFEN - A NEW NONSTEROIDAL ANTIINFLAMMATORY DRUG - PHARMACOLOGY, CLINICAL EFFICACY AND ADVERSE-EFFECTS.PHARMACOTHERAPY. VOL. 7. ISSUE 1. P. 16-24 | 14 | 41% | 28 |
| 2 | KASHYAP, A , SAHA, K , SEHGAL, VN , (1992) RECONSTRUCTION OF ANTILEPROSY DRUG DEPLETED COMPLEMENT HEMOLYTIC-ACTIVITY BY ADDITION OF ZYMOSAN-TREATED SERA (A SOURCE OF C142) AND CRATEDTA (A SOURCE OF C3-C9).INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY. VOL. 14. ISSUE 8. P. 1409-1414 | 6 | 60% | 1 |
| 3 | ARAUJO, MNT , LESER, PG , GABRIEL, A , ASSAD, RL , ATRA, E , (1991) A SIMPLE RADIAL IMMUNOHEMOLYSIS ASSAY FOR THE MEASUREMENT OF FUNCTIONAL COMPLEMENT C2 ACTIVITY.BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH. VOL. 24. ISSUE 1. P. 49-57 | 4 | 80% | 4 |
| 4 | JALAVA, S , (1983) A DOUBLE-BLIND CROSSOVER STUDY OF CARPROFEN AND INDOMETHACIN IN PATIENTS WITH RHEUMATOID-ARTHRITIS.SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. VOL. . ISSUE . P. 5-9 | 4 | 100% | 0 |
| 5 | ASGHAR, SS , DEKOSTER, A , VANDERHELM, HJ , (1986) INVITRO INHIBITION OF THE CLASSICAL PATHWAY OF HUMAN-COMPLEMENT BY A NATURAL MICROBIAL PRODUCT, COLISTIN SULFATE.BIOCHEMICAL PHARMACOLOGY. VOL. 35. ISSUE 17. P. 2917-2921 | 5 | 63% | 0 |
| 6 | ASGHAR, SS , OUT, J , (1986) NEW METHODS FOR THE PREPARATION OF THE CELLULAR-INTERMEDIATE EAC14BAR.JOURNAL OF IMMUNOLOGICAL METHODS. VOL. 95. ISSUE 2. P. 277-281 | 3 | 100% | 1 |
| 7 | KAMMEYER, A , ABDELMAWLA, MYM , OOSTERHOORN, AD , AMER, M , ASGHAR, SS , (1990) INHIBITION OF CELLULAR INFILTRATION AT THE SITE OF ARTHUS REACTION BY CHLORPROMAZINE - USE OF A NEW AREA INTEGRATION TECHNIQUE.INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY. VOL. 12. ISSUE 6. P. 685-690 | 3 | 75% | 0 |
| 8 | ROSS, AJ , DELMAURO, MD , CASEY, DL , SOKOLOFF, HK , (1984) ANALYSIS OF CARPROFEN DOSAGE FORMS AND DRUG SUBSTANCE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 73. ISSUE 9. P. 1211-1215 | 4 | 67% | 4 |
| 9 | KASHYAP, A , SEHGAL, VN , SAHU, A , SAHA, K , (1992) ANTILEPROSY DRUGS INHIBIT THE COMPLEMENT-MEDIATED SOLUBILIZATION OF PREFORMED IMMUNE-COMPLEXES INVITRO.INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY. VOL. 14. ISSUE 2. P. 269-273 | 4 | 36% | 4 |
| 10 | SIMILA, S , KEINANENKIUKAANNIEMI, S , KYLMAMAA, T , (1982) ANTI-PYRETIC EFFECT OF CARPROFEN AND PARACETAMOL IN FEVER IN CHILDREN.CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL. VOL. 32. ISSUE 1. P. 53-58 | 3 | 75% | 2 |
Classes with closest relation at Level 1 |